Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not …
Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of
morbidity and mortality in patients with established disease. Secular trends in the …
morbidity and mortality in patients with established disease. Secular trends in the …
Optimizing foundational therapies in patients with HFrEF: how do we translate these findings into clinical care?
Given the high risk of adverse outcomes in patients with heart failure and reduced ejection
fraction (HFrEF), there is an urgent need for the initiation and titration of guideline-directed …
fraction (HFrEF), there is an urgent need for the initiation and titration of guideline-directed …
Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: a network meta-analysis
Background—Treatments that reduce mortality and morbidity in patients with heart failure
with reduced ejection fraction, including angiotensin-converting enzyme inhibitors (ACEI) …
with reduced ejection fraction, including angiotensin-converting enzyme inhibitors (ACEI) …
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Background Ivabradine specifically inhibits the I f current in the sinoatrial node to lower heart
rate, without affecting other aspects of cardiac function. We aimed to test whether lowering …
rate, without affecting other aspects of cardiac function. We aimed to test whether lowering …
Conventional heart failure therapy in cardiac ATTR amyloidosis
A Ioannou, P Massa, RK Patel, Y Razvi… - European Heart …, 2023 - academic.oup.com
Aims The aims of this study were to assess prescription patterns, dosages, discontinuation
rates, and association with prognosis of conventional heart failure medications in patients …
rates, and association with prognosis of conventional heart failure medications in patients …
Chronic kidney disease as a comorbidity in heart failure
M Szlagor, J Dybiec, E Młynarska, J Rysz… - International Journal of …, 2023 - mdpi.com
Heart failure (HF) is one of the greatest problems in healthcare and it often coexists with
declining renal function. The pathophysiology between the heart and the kidneys is …
declining renal function. The pathophysiology between the heart and the kidneys is …
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and …
PG Shekelle, MW Rich, SC Morton… - Journal of the American …, 2003 - jacc.org
Objectives: This study sought to assess the effect of angiotensin-converting enzyme (ACE)
inhibitors and beta-blockers on all-cause mortality in patients with left ventricular (LV) …
inhibitors and beta-blockers on all-cause mortality in patients with left ventricular (LV) …
Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995
Background—Contemporary survival in unselected patients with heart failure and the
population impact of newer therapies have not been widely studied. Therefore, we have …
population impact of newer therapies have not been widely studied. Therefore, we have …
Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in …
BACKGROUND: Atrial fibrillation (AF) is frequent in patients with chronic heart failure (CHF).
Experimental and small patient studies have demonstrated that blocking the renin …
Experimental and small patient studies have demonstrated that blocking the renin …
Emerging topics update of the Brazilian heart failure Guideline–2021
FG Marcondes-Braga, LAZ Moura, VS Issa… - Arquivos brasileiros de …, 2021 - SciELO Brasil
The latest Heart Failure Guidelines by the Department of Heart Failure of the Brazilian
Society of Cardiology (DEIC/SBC) were finalized on March 2018. Since then, a significant …
Society of Cardiology (DEIC/SBC) were finalized on March 2018. Since then, a significant …